Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Jan-Feb;11(1):77-84.

Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin

Affiliations
Comparative Study

Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin

Bryan D Maliken et al. Ann Hepatol. 2012 Jan-Feb.

Abstract

Background: There is an ongoing clinical need for novel methods to measure hepatic iron content (HIC) noninvasively. Both magnetic resonance imaging (MRI) and superconducting quantum interference device (SQUID) methods have previously shown promise for estimation of HIC, but these methods can be expensive and are not widely available. Room-temperature susceptometry (RTS) represents an inexpensive alternative and was previously found to be strongly correlated with HIC estimated by SQUID measurements among patients with transfusional iron overload related to thalassemia.

Aim: The goal of the current study was to examine the relationship between RTS and biochemical HIC measured in liver biopsy specimens in a more varied patient cohort.

Material and methods: Susceptometry was performed in a diverse group of patients with hyperferritinemia due to hereditary hemochromatosis (HHC) (n = 2), secondary iron overload (n = 3), nonalcoholic fatty liver disease (NAFLD) (n = 2), and chronic viral hepatitis (n = 3) within one month of liver biopsy in the absence of iron depletion therapy.

Results: The correlation coefficient between HIC estimated by susceptometry and by biochemical iron measurement in liver tissue was 0.71 (p = 0.022). Variance between liver iron measurement and susceptometry measurement was primarily related to reliance on the patient's body-mass index (BMI) to estimate the magnetic susceptibility of tissue overlying the liver.

Conclusions: We believe RTS holds promise for noninvasive measurement of HIC. Improved measurement techniques, including more accurate overlayer correction, may further improve the accuracy of liver susceptometry in patients with liver disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Room-temperature susceptometer
Patients lay on their side below the field-producing coils as the susceptometer recorded changes in the magnetic field induced by hepatic iron.
Figure 2
Figure 2. Two-layer model used in liver-iron calculation
In the diagram, zSS is the distance from the patient’s skin to the bottom of the susceptometer, and zLS is the liver-skin distance measured by ultrasound. These values are used in Eq. (1) to account for alterations in susceptometry measurements due to increasing distance and changes in the magnetic field from non-hepatic tissue.
Figure 3
Figure 3. Correlation between liver iron concentrations determined by room-temperature susceptometry (HICRTS) and biochemical hepatic iron content of biopsy specimens (HICbiopsy)
The mean of 12 measurements are plotted for HICRTS with error bars to display standard deviation. Pearson’s correlation with 95 percent confidence interval band is shown with r-and p-values provided.
Figure 4
Figure 4. Association between the magnitude of susceptometry-HIC difference and liver-skin distance
Liver-skin distance was determined by ultrasound at the chosen point of measurement. Accuracy of RTS measurements was determined by finding the absolute difference between HICRTS and HICbiopsy (i.e. Error = |HICRTS − HICbiopsy|). Pearson’s correlation with 95 percent confidence interval band is shown with r-and p-values provided.

Similar articles

Cited by

References

    1. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003;30:137–144. - PubMed
    1. Terry R. Risks of needle biopsy of the liver. Br Med J. 1952;1:1102–1105. - PMC - PubMed
    1. Zamcheck N, Klasusenstock O. Liver biopsy. II. The risk of needle biopsy. N Engl J Med. 1953;249:1062–1069. - PubMed
    1. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005;123:146–152. - PubMed
    1. Nielsen P, Gunther U, Durken M, Fischer R, Dullmann J. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med. 2000;135:413–418. - PubMed

Publication types

MeSH terms